frequent
tell
young
prospect
research
student
respiratori
infect
great
area
develop
expertis
unlik
cancer
cardiovascular
diseas
guarante
problem
solv
go
away
lifetim
burden
respiratori
infecti
diseas
larg
acut
also
due
chronic
complic
lower
respiratori
tract
infect
remain
number
one
caus
death
develop
world
develop
world
lower
respiratori
tract
infect
still
fifth
lead
caus
death
increas
age
gener
popul
countri
abil
keep
peopl
succumb
chronic
organ
failur
ever
increas
array
immunosuppress
drug
use
varieti
neoplast
immun
diseas
ensur
ever
increas
pool
vulner
host
well
host
factor
speed
adapt
pathogen
make
like
conquer
death
respiratori
infect
time
soon
progress
made
reduc
pneumococc
diseas
newer
conjug
vaccin
evid
speed
adapt
measur
proport
strain
cover
vaccin
increas
adapt
pathogen
pose
challeng
multipl
area
includ
drugresist
tuberculosi
panresist
gramneg
pathogen
ever
increas
rate
communityacquir
methicillinresist
staphylococcu
aureu
mani
western
countri
adapt
exist
pathogen
progress
encroach
human
habitat
seen
rise
new
pathogen
coronavirus
caus
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
well
novel
influenza
strain
avian
strain
notabl
except
viral
infect
associ
sever
diseas
high
mortal
rate
seri
respiratori
infect
respirolog
mani
abovement
challeng
cover
includ
burden
diseas
due
respiratori
pathogen
acut
longterm
drugresist
pathogen
newli
emerg
pathogen
review
focu
key
area
evid
around
best
practic
care
patient
respiratori
infect
key
differ
respiratori
pathogen
differ
area
particular
relev
asiapacif
region
hope
reader
respirolog
find
review
use
resourc
clinic
inspir
get
involv
research
sinc
bug
stand
still
neither
disclosur
statement
gw
paid
attend
advisori
board
menarini
pharmaceut
school
medicin
univers
western
australia
perth
western
australia
australia
